Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial (NEXT)

This study has been completed.
Information provided by (Responsible Party):
Takeshi Morimoto, Kyoto University, Graduate School of Medicine Identifier:
First received: February 24, 2011
Last updated: December 9, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):